MedTrace Logo

Maine Implementation Study - Phase III

NCT02229305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2014-09-01

No results posted yet for this study

Summary

This study focused on youths who were referred to community-based mental healths clinics for problems related to disruptive behaviors, depression, anxiety, traumatic stress, and any combination of these problems. Therapists were randomly assigned to deliver usual treatment procedures (usual care, or UC) in their clinics or an evidence-based, modularized treatment (Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems, or MATCH-ADTC). Assessments were conducted at pre-treatment and post-treatment, and every 3 to 6 months for two years. Results will address critical questions about deployment of evidence-based youth practices to clinical settings.

Conditions

Interventions

BEHAVIORAL

Usual Care Treatment

Usual Care therapists could use any treatment procedures they used regularly in their clinical practice.

BEHAVIORAL

Modular Approach to Therapy for Children

Therapists used the Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems (MATCH-ADTC; Chorpita \& Weisz, 2010).

Sponsors & Collaborators

  • MacArthur Foundation

    collaborator OTHER

  • Casey Family Programs

    collaborator UNKNOWN

  • Annie E. Casey Foundation

    collaborator OTHER_GOV

  • Harvard University

    lead OTHER

Principal Investigators

  • John R Weisz, PhD · Harvard University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229305 on ClinicalTrials.gov